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Abstract
BACKGROUND: Acute motor axonal neuropathy (AMAN) is a peripheral nerve disorder that attacks motor axons 
and occurs acutely. AMAN is one type of Guillain–Barre syndrome (GBS) which often attacks men of productive age. 
Until now, although patients have undergone intravenous immunoglobulin (IVIG) therapy and/or plasmapheresis, 
long-standing disability remains a problem. In Indonesia, the availability and cost of these therapies are constraints.
AIM: Our study aimed to find a proper animal model suitable for AMAN and can be executed in our institution, Naval 
Health Institute with a hope to find new therapeutic modalities in healing with AMAN.
METHODS: GM1 ganglioside immunized in New Zealand male white rabbits with complete Freund’s adjuvant, every 
3 weeks until 20 weeks. We evaluated the effects GM1 ganglioside on body weight, functional score, and axon 
degeneration’s scale. Functional score was examined based on Tarlov’s. Hematoxylin-eosin was used to stain this 
slide.
RESULTS: Rabbits that being immunized with GM1 ganglioside experience a number of neurological signs and 
symptoms that resemble AMAN, that is, sluggish righting reflex, muscular weakness, flaccid hyper paralysis, and 
body weight loss. Pathological examination shows extensive degeneration of peripheral nerves, infiltration of 
macrophages, and perineuritis.
CONCLUSION: This histological and clinical findings support that this neuropathy is induced by an autoimmune 
response delivered by cells that respond to gangliosides.
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Introduction
Acute motor axonal neuropathy (AMAN) is 
a primary axonal disorder that affects only the motor 
nerves and the second most type of Guillain–Barre 
syndrome (GBS). GBS is an autoimmune disease with 
demyelinating peripheral nerves that cause ascending 
and progressive muscle weakness [1]. AMAN is 10–20% 
of GBS sporadic cases that have an incidence of about 
1/100,000 [2]. The incidence increases from 0.62/100.00 
children to 2.66/100,000 ages 80–89 years. The ratio of 
male to female is 3:2. Neurological symptoms last up to 
20% with severe disabilities. More than 80% occur severe 
fatigue and persist after resolution of other symptoms [3]. 
Mortality rates in Europe and North America vary 
between 3 and 7% [4]. Intravenous immunoglobulin 
(IVIG) and plasmapheresis (PE) are effective for GBS 
patients if given the first few weeks. Even though, 
persistent disability is seen in 20–30% of adult GBS 
patients [5]. In Indonesia, however, both modalities are 
quite expensive. For this reason, the researcher decided 
to try finding other alternative therapeutic options using 
animal models that could represent AMAN.
There have been three ways to model animals 
for neurological dysfunction in GM1-immunized animals. 
The first way is by Nagai, GM1-immunized rabbits 
experience spastic paralysis. Histologically, phagocytic 
cells containing myelin debris can be observed. Another 
study by Thomas, rabbits experienced subclinical 
neuropathy. Mild axonal degeneration of the sciatic 
nerve and IgM deposits in Ranvi nodes is obtained. 
This discovery did not occur in mice. Conversely, 
sensitization of rabbits with GD1b induces sensory 
neuropathy associated with anti-GD1b antibodies. This 
confirms that failure to induce neuropathy by sensitizing 
with ganglioside depends on the susceptibility of the 
species and to the immunization procedure used [6]. 
Therefore, in the third study, rabbits were inoculated 
with a mixture of bovine brain ganglioside (BBG) 
according to the Kusunoki et al. procedure. Rabbits 
have AMAN associated with anti-GM1 IgG antibodies. 
Experimental motor axonal neuropathy is also induced 
by sensitization with GM1 [7].
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The purpose of this journal is to explain the 
results obtained in making an AMAN animal model 
according to Yuki in our hyperbaric laboratory.
Materials and Methods
The researcher modeled the axonal GBS 
type by imitating the modified Yuki method. Male New 
Zealand white rabbit, weighing 2.0 kg, obtained from 
Tuban Animal Husbandry. These rabbits were given 0.5 
mg ganglioside GM1 dissolved in 0.5 ml limpet keyhole 
hemocyanin (KLH) in phosphate buffer saline (PBS). 
Half an mg of the complete Freund supplement (FCA) is 
added and the mixture emulsified. A 1 ml GM1 emulsion 
sample was injected subcutaneously on the back and 
intraperitoneally at intervals of 3 weeks until there was a 
weakness in the locomotion. Rabbits are checked daily 
for clinical signs and weighed once a week. All animal 
procedures refer to the institutional guidelines of the 
Faculty of Veterinary Medicine, Airlangga University.
Motor strength according to Tarlov modification [8] 
is no limb function – back or dead (0), only joint motion (1), 
active motion but unable to stand (2), able to stand but 
unable to walk (3), and normal movement function (4).
Variable measurement studies were conducted 
in 14 rabbits, divided into two groups. The first seven 
groups were normal rabbits and the last were rabbits that 
inoculated with GM1. All data were analyzed using IBM 
SPSS version 22.0. The significance level for statistical 
analyzes p < 0.05 was considered statistically significant.
Pathological studies
Rabbits were deeply anesthetized by an 
intraperitoneal injection of ketamine. The right sciatic 
nerves and the lumbar spine were removed for light 
microscopic analysis. Nerve specimens were immersed 
directly in 10% formaldehyde and stained with 
hematoxylin-eosin and examined. The preparations 
were blindly assessed by pathology anatomist, who was 
blinded to the experimental procedure and sampled 
region. Differences in the frequency distribution of 
macrophage infiltration and perineuritis were statistically 
examined with the Mann–Whitney U-test.
The image analysis program Mascope was used 
for morphological examination of the sciatic nerves. Digital 
photo images were obtained with a light microscope 
with a final magnification of ×400 and an attached CCD 
camera interfaced with a computer. Both the central and 
peripheral nervous system are assessed. For the central 
nervous system, in this case, the lumbar vertebrae, 
the number of macrophages, and neuron edema are 
assessed. The number of macrophages is calculated per 
three visual fields and the average is taken. Neuronal 
edema is measured manually by the distance between 
the walls of the neuron and its neurons in both the cross-
section and the mean were taken. As for the peripheral 
nervous system, what is concerned is the pattern of 
undulation. This undulation pattern is measured manually 
by drawing a straight line between two formations such 
as a mountain as far as 2 cm and reading the height 
of a straight line. The scoring of amount of neuron was 
undertaken width of neuron edema, neutrophil infiltration, 
and perineuritis on a scale of 1–4 as follows: 1 = none or 
minor; 2 = modest; 3 = intermediate; and 4 = prominent.
Results
Effects of GM1 in body weight and motor 
function
Of the 10 control rabbits, none show weakness 
locomotor until the end of examination time (20 weeks). 
In contrast, all 10 rabbits immunized with IgGM1 show 
flaccid paresis of locomotor hind, with the start time of 
events ranging from 71 to 107 days (mean 92 days) 
after the first inoculation. Seven rabbits immunized 
GM1, begin to experience weight loss in <8 weeks. 
Weight reduction is in accordance with the conditions of 
rabbits began inexhaustible food rations and drinking. 
When these rabbits start weight loss consistent for 2 
weeks, it is considered as the onset of the disease. After 
experiencing weight loss, they start to have weakness of 
locomotor. The weight on this group was calculated when 
the terminated decline of about 0.1–0.3 is calculated from 
the initial onset of clinical sign (week 8–10) (Table 1).
Table 1: Rabbits inoculated with GM1
Rabbit Inoculation 
times
The onset of limb 
weakness
Days from onset 
to peak
Poorest functional 
grade
Body weight 
at 0WK
Body weight at 
10WK
Bodyweight at 
16WK
Body weight 
at 20WK
Axon degenerative 
scale
GM1-1 4 97 6 2 2,1 2.4 2.3 2.3 4
GM1-2 4 71 26 0 2.2 2.4 2 2.0 3
GM1-3 4 94 29 3 2.1 2.5 2.2 2.2 4
GM1-4 4 75 33 0 2.0 2.3 2.1 2.1 4
GM1-5 4 99 38 1 1.8 2.2 2 2.0 4
GM1-6 4 103 17 2 2.2 2.1 2.2 2.2 4
GM1-7 4 107 23 2 2.0 2.2 2.3 2.3 3
N-1 0 0 0 4 2.2 2.5 2.7 2.9 1
N-2 0 0 0 4 2.2 2.4 2.8 3.0 1
N-3 0 0 0 4 2.1 2.5 2.6 2.9 1
N-4 0 0 0 4 2 2.5 2.7 2.8 1
N-5 0 0 0 4 2 2.5 2.6 2.7 1
N-6 0 0 0 4 1.8 2.4 2.7 2.8 1
N-7 0 0 0 4 1.9 2.5 2.6 2.9 1
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Rabbits GM1-3, GM1-4, and GM1-7 had 
tremors a few days before the start of locomotor 
weakness. Weakness locomotor becomes progressively 
during 4–13 days (median 5 days) after the start of the 
weakness in seven rabbits until it reaches a constant 
value. Tetraparesis occurs rapidly in rabbits GM1-2 and 
GM1-4, with breathing became labored and gasping. 
After the commencement of locomotor weakness, they 
die, respectively, on day 36 and 41 (Figures 1 and 2).
At approximately the same time, the equivalent 
of rabbits in the control group terminated. There is no 
weight loss in the control group. Instead, the weight 
raised up ranged 0.7 until 1 kg. There were significantly 
different between body weights from two groups at 
week 16 (p = 0.002) and 20 (p = 0.002).
the boundary between the two areas is similar and 
difficult to identify. Whereas in the analysis of normal 
sciatic nerves with HE staining, it is possible to observe 
tissue patterns with special undulation and parallel 
organization of nerve fibers. Myelin sheath painting is 
weak and unspecified, with very low contrast between 
various histological structures.
The sagittal (left) sacral section of a normal 
rabbit found less than 20 macrophages infiltration. The 
neuron cells size appear normal, without interneuron 
edema. The longitudinal (right) section shows a unique 
undulation pattern with a straight line-height between 
two mountain-like formations over 3 cm. There were 
no signs of axon degeneration in the normal ischiadica 
nerve’s rabbits.
Morphological analysis by HE painting after 20 
weeks of in vivo immunization enables observing axonal 
degeneration. The number of macrophages increases 
with minimal lymphocyte infiltration. Interneuron edema 
increases approximately 1–2.4 mm at ×400. There are also 
neurons with apoptotic material. There was no difference 
in the number of blood vessels in the two groups.
Figure 3: The sagittal (left) section of the normal rabbit myelum is 
seen with normal macrophage infiltration and neuron cells with normal 
size, without intraneuronal edema. Longitudinal (right) chunks of the 
normal rabbit are chiadika nerve appear typical undulation patterns.
Figure 4: (a) Sagittal cross-section of the sacral (left) shows 
macrophage infiltration and neuronal edema in rabbit-immunized HE 
prepared rabbits. (b) Longitudinal cross-section of the sciatic nerve 
(right) showing a flat pattern of undulation.
ba
Figure 2: (a) GM1-2 rabbit with locomotion weakness 10 days after 
onset. Rabbit cannot maintain a normal standing position or lift their 
head and body. Muscle locomotion and body are weak and sagging, 
giving less resistance generally in passive movements. (b) GM1-5 
rabbit with locomotion weakness 15 days after onset. The rabbit is 
less capable of moving the hint, moving only with both hands. They 
try to jump but cannot. (c) GM1-4 rabbit with locomotion weakness 
29 days after onset. Forty-one days after onset, the rabbit dies, there 
is no vital sign.
a c
b
Figure 1: Rabbit GM1-1 (left) at the beginning of the study and rabbit 
Cr-1 (right) at the end of the study. Rabbits with straight ears can 
maintain a normal standing position and lift the head and body.
Histological findings
There were no changes in the bone marrow or 
the sciatic nerves of all rabbits that were not immunized 
GM1. In lumbar fragments painted with HE, tissue 
patterns can be observed, which make it possible to 
recognize gray matter and white matter, even though 
In the sciatic nerve, a typical undulation 
tissue pattern is observed from the peripheral nerve 
with Wallerian degeneration. Histochemical reactions 
to collagen fibers are intense and fibers tend to stay 
oriented in place. In longitudinal sections, structural 
disorganization with a straight line height between 
the two mountain-like formations is <2.5 cm. In some 
rabbits, this undulation is almost completely gone. 
There were also significantly different between axon 
degenerations at week 20 (p = 0.02) (Figures 3 and 4).
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Discussion
GBS is an acute disease that attacks the 
peripheral nerves. The disorder commonly presents with 
a weakness that is often symmetric and most often begins 
in the legs. Autonomic involvement is common and may 
lead to a fatal outcome, as may aspiration pneumonia 
or impaired respiration from weakness [9]. GBS has a 
serious long-term impact on the patients’ work and private 
life, even 3–6 years after the onset of the illness [5]. 
Several subtypes of GBS are now recognized, 
as determined primarily by electrodiagnostic and 
pathologic distinction. Although they have received 
standard therapy, namely, IVIG and plasmapheresis, the 
disability remains a problem [9]. Axonal type is the most 
common type in Indonesia with AMAN being the most 
frequent. The cost of standard therapy is a problem. 
In our institution, AMAN patients who receive oxygen 
hyperbaric get a faster motor repair. We try to reduce it 
to research using experimental animals. Unfortunately, 
AMAN model does not yet exist in Indonesia.
The use of the rabbit as an animal model for 
studying human biology is based on the phylogenetic 
relationship, the similarity of anatomy, physiology, and 
behavior of humans. Rabbits have an advantage with the 
size of the middle between rodents and larger animals 
and more expensive, such as primates. Rabbit size allows 
blood samples sap and greater access to many cells and 
tissues. In addition, rabbits have a life span longer than 
rodents, and genes of the immune system of rabbits 
appear to be more similar to the human immune system 
genes than rodents. Rabbits also are carriers or reservoirs 
of some zoonotic pathogens that cause disease.
Of the seven rabbits given GM1 immunization, 
we got signs and weakness symptoms that were very 
similar to patients with GBS axonal type. Nagai observed 
that rabbits immunized intensively with bovine brain 
ganglioside or certain molecules from ganglioside species, 
such as GD1a and GM1 in CFA will experience various 
neurological symptoms and signs that closely resemble 
experimental allergic encephalomyelitis [10]. Some 
rabbits experience initial symptoms such as tremors. 
On average at week 8, rabbits begin to experience a 
decrease in appetite and drinking. Two weeks after the 
decrease in intake, weight loss was recorded from 0.1 to 
0.2 kg. Clinical symptoms in the form of motor weakness 
appear a week after this with a decrease in the agility 
of the back motion until it can only move the front. Two 
rabbits die on the day 36 and 41 after symptoms begin.
In terms of pathology observations, painting 
hematoxylin and eosin (H&E) is the easiest and the most 
frequent staining that is often used for light microscopy 
and even for peripheral nerve [11]. It is known that light 
microscopy can detect peripheral nerve damage. Even 
though this strain is not an ideal method for analyzing 
the nerve regeneration process, its electropolar nature 
can make H&E used. As we know, this stain will 
produce pink and purple color with various intensities in 
neural elements. Any degenerative nerve will be shown 
as vacuole (vacuolated foci). An empty zone is the 
characteristic of myelin with this staining [12].
The sciatic nerves showed severe to mild 
Wallerian-like degeneration, with an increasingly flat 
form of undulation. There is the invasion of macrophage 
in the endoneurial-perivascular region, but there was 
not any infiltration of lymphocytes in any of sciatic nerve 
regions. These results suggest that this syndrome may 
be induced by cell-delivered autoimmune responses 
that respond to gangliosides [7]. Thomas stated mild 
axon degeneration and immunoglobulin deposits in 
the Ranvier node in the peripheral nerves, resembling 
morphic neuropathy patients, motor conduction blocks, 
and anti-GM1 antibodies [6].
At GBS cases, molecular mimicry happens. 
Microbial antigens may cross-react with self-antigens. 
Therefore, immune responses initiated by the microbes 
may activate T cells specific for self-antigens [13]. 
In the autopsy case, perivascular and endoneurial 
inflammatory infiltrate is observed in all nerves, nerve 
roots, or plexus during segmental demyelination 
delivered by macrophages, especially in areas with 
lymphoid infiltrates [14]. The electrophysiological 
analysis shows that anti-GM1 antibodies occur more 
frequently in groups of patients with inexcitable axonal or 
nerve injury [7]. The AMAN study after C. jejuni infection 
provides strong evidence of the concept of molecular 
mimicry in the pathophysiology of immune neuropathy. 
The relationship between AMAN and previous 
Campylobacter infections fulfills four criteria that meet 
molecular mimicry: Epidemiological relationships 
between GBS and C. jejuni infections, identification 
of direct antibodies to host antigens (gangliosides) in 
patients, identification of microbial mimics on target 
antigens, and experimental neuropathy development in 
animal models [15].
Changes that occur due to GM1 immunization 
are seen both in the central nervous system and 
peripheral nerves. Although AMAN is peripheral 
neuropathy, we can also see slight changes in the 
lumbar bone marrow in this preparation. This study is 
expected to be the basis for making the first AMAN 
model in Indonesia. Provision of other adjunctive 
therapies can be given on this model, even better when 
compared with standard therapy.
Conclusion
The clinical picture of weakness with a trip 
monophasic and acute-GM1 immunized rabbits similar to 
that occurring in patients with GBS. GBS type of axonal has 
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a dominant axonal involvement, characterized by similar 
Wallerian degeneration in HE staining, with only minimal 
demyelination occurs and infiltration of lymphocytes. 
Paralysis rabbits showed the same pathological changes 
predominantly axonal degeneration in peripheral nerves.
In conclusion, the inoculation experiment 
of rabbits with GM1 has been successfully proved in 
presenting a new model for molecular pathogenesis 
determination for axonal type. To see the better view 
of nerve regeneration in light microscopy, we suggest 
using another method such as Marchi. Hopefully, this 
model can be used in finding new alternative therapies 
for patients with GBS, more specifically in axonal types.
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